Markets:

Overview

News

Currencies

International

Treasuries

Viatris Inc. - Common Stock (NQ:VTRS)

12.57 +0.21 (+1.66%)

Streaming Delayed Price Updated: 11:06 AM EST, Jan 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Viatris Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

1 Healthcare Stock to Target This Week and 2 We Turn Down

January 05, 2026

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 17.2% over...

Via StockStory

Topics Stocks

1 Momentum Stock to Target This Week and 2 That Underwhelm

December 31, 2025

The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant...

Via StockStory

Delek Shares Surge 60% but One Fund Walked Away From a $15 Million Position ↗

December 31, 2025

The exit comes after a huge run for the stock, but there's more to it than timing alone.

Via The Motley Fool

Topics Energy

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Why One Fund Made a $19 Million Bet on Four Corners Property Trust Even as Shares Fell 15% ↗

December 29, 2025

This quiet REIT move looks less like bargain hunting and more like a calculated play on cash flow durability.

Via The Motley Fool

Topics Regulatory Compliance

Prescription for Growth: Why Zoetis and Viatris are Defining Healthcare’s New Winners in 2025

December 24, 2025

As the curtain closes on 2025, the healthcare sector has emerged as a landscape of stark contrasts. While traditional pharmaceutical giants have grappled with the implementation of the Medicare Part D...

Via MarketMinute

Topics Bonds Earnings World Trade

Exploring the top movers within the S&P500 index during today's session. ↗

December 24, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.

Via Chartmill

1 S&P 500 Stock with Impressive Fundamentals and 2 That Underwhelm

December 18, 2025

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...

Via StockStory

Topics Stocks

Global Prescription Drug Market Poised for Trillion-Dollar Surge by 2035

December 03, 2025

The global prescription drugs market is on the cusp of a significant expansion, with recent market reviews and forecasts projecting a robust growth trajectory through 2035. This anticipated surge,...

Via MarketMinute

Topics Artificial Intelligence Death Intellectual Property

Pfizer, UnitedHealth, Viatris, Addus HomeCare, and Quest Stocks Trade Up, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut.

Via StockStory

Topics Economy

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields ↗

November 14, 2025

Via Benzinga

Reflecting On Generic Pharmaceuticals Stocks’ Q3 Earnings: Viatris (NASDAQ:VTRS)

November 12, 2025

Wrapping up Q3 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including Viatris (NASDAQ:VTRS) and its peers.

Via StockStory

Topics Artificial Intelligence Intellectual Property

What's going on in today's session: S&P500 gap up and gap down stocks ↗

November 12, 2025

Stay tuned for the market movements in the S&P500 index on Wednesday. Check out the gap up and gap down stocks in the S&P500 index during today's session.

Via Chartmill

3 Unprofitable Stocks That Concern Us

November 11, 2025

Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital...

Via StockStory

Viatris, Oscar Health, BioMarin Pharmaceutical, QuidelOrtho, and Bausch + Lomb Stocks Trade Up, What You Need To Know

November 11, 2025

A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid...

Via StockStory

Topics Artificial Intelligence Stocks

Exploring the top movers within the S&P500 index during today's session. ↗

November 11, 2025

Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session.

Via Chartmill

Wall Street Pauses, Silver Reclaims $50 With Shutdown End In Sight: What's Moving Markets Tuesday? ↗

November 11, 2025

U.S. equities took a breather on Tuesday, stabilizing after Monday's sharp rally as investors awaited a House vote on the temporary spending bill expected to end the record-long government shutdown...

Via Benzinga

What's going on in today's session: S&P500 movers ↗

November 11, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

Viatris (VTRS) Q3 2025 Earnings Call Transcript ↗

November 06, 2025

Viatris (VTRS) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

VIATRIS INC (NASDAQ:VTRS) Q3 2025 Earnings Beat Expectations ↗

November 06, 2025

Viatris beats Q3 2025 earnings estimates with strong EPS of $0.67, showcasing solid profitability and operational execution.

Via Chartmill

Topics Earnings

Viatris’s (NASDAQ:VTRS) Q3 Sales Top Estimates

November 06, 2025

Medication company Viatris (NASDAQ:VTRS) beat Wall Street’s revenue expectations in Q3 CY2025, but sales were flat year on year at $3.76 billion. The company’s full-year revenue guidance of $14.1...

Via StockStory

Viatris (VTRS) Q3 Earnings Report Preview: What To Look For

November 04, 2025

Medication company Viatris (NASDAQ:VTRS) will be reporting earnings this Thursday before market open. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence

3 Stocks Under $50 We’re Skeptical Of

November 02, 2025

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some...

Via StockStory

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields ↗

October 30, 2025

Via Benzinga

1 S&P 500 Stock to Target This Week and 2 We Brush Off

October 29, 2025

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth,...

Via StockStory

Topics Stocks

What Occidental Petroleum’s Latest Backer Sees in Oil’s Next Chapter ↗

October 24, 2025

What Occidental Petroleum’s Latest Backer Sees in Oil’s Next Chapter

Via The Motley Fool

Topics Energy Regulatory Compliance

3 Volatile Stocks with Warning Signs

October 24, 2025

Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor...

Via StockStory

Topics Artificial Intelligence

3 Reasons to Sell VTRS and 1 Stock to Buy Instead

October 22, 2025

Viatris’s 35.8% return over the past six months has outpaced the S&P 500 by 8.4%, and its stock price has climbed to $10.44 per share. This was partly due to its solid quarterly results, and the run-up...

Via StockStory

Topics Government Stocks World Trade

QSM Asset Management Takes $11.5 Million Stake in Rio Tinto, Expands Energy Exposure ↗

October 16, 2025

Via The Motley Fool

QSM Asset Management Buys $6.8 Million of Pfizer Stock as Pharma Giant Lags Market ↗

October 16, 2025

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.